ID   DYRK4_HUMAN             Reviewed;         520 AA.
AC   Q9NR20; A8K8F7; Q8NEF2; Q92631;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2005, sequence version 2.
DT   12-OCT-2022, entry version 183.
DE   RecName: Full=Dual specificity tyrosine-phosphorylation-regulated kinase 4;
DE            EC=2.7.12.1;
GN   Name=DYRK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANTS ILE-95 AND SER-189.
RC   TISSUE=Brain, and Kidney;
RX   PubMed=11062477; DOI=10.1038/81664;
RA   White K.E., Evans W.E., O'Riordan J.L.H., Speer M.C., Econs M.J.,
RA   Lorenz-Depiereux B., Grabowski M., Meitinger T., Strom T.M.;
RT   "Autosomal dominant hypophosphataemic rickets is associated with mutations
RT   in FGF23.";
RL   Nat. Genet. 26:345-348(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1-430 (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 280-520 (ISOFORM 2).
RC   TISSUE=Lung;
RX   PubMed=9748265; DOI=10.1074/jbc.273.40.25893;
RA   Becker W., Weber Y., Wetzel K., Eirmbter K., Tejedor F.J., Joost H.-G.;
RT   "Sequence characteristics, subcellular localization, and substrate
RT   specificity of DYRK-related kinases, a novel family of dual specificity
RT   protein kinases.";
RL   J. Biol. Chem. 273:25893-25902(1998).
RN   [5]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-133.
RX   PubMed=17292540; DOI=10.1016/j.mce.2006.12.041;
RA   Sacher F., Moeller C., Bone W., Gottwald U., Fritsch M.;
RT   "The expression of the testis-specific Dyrk4 kinase is highly restricted to
RT   step 8 spermatids but is not required for male fertility in mice.";
RL   Mol. Cell. Endocrinol. 267:80-88(2007).
RN   [6]
RP   ALTERNATIVE SPLICING (ISOFORMS 4 AND 5), SUBCELLULAR LOCATION (ISOFORM 4),
RP   MUTAGENESIS OF TYR-264, AND PHOSPHORYLATION AT TYR-264.
RX   PubMed=21127067; DOI=10.1074/jbc.m110.157909;
RA   Papadopoulos C., Arato K., Lilienthal E., Zerweck J., Schutkowski M.,
RA   Chatain N., Muller-Newen G., Becker W., de la Luna S.;
RT   "Splice variants of the dual specificity tyrosine phosphorylation-regulated
RT   kinase 4 (DYRK4) differ in their subcellular localization and catalytic
RT   activity.";
RL   J. Biol. Chem. 286:5494-5505(2011).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-70.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Possible non-essential role in spermiogenesis. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.12.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.12.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.12.1;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- INTERACTION:
CC       Q9NR20; Q92630: DYRK2; NbExp=3; IntAct=EBI-3914009, EBI-749432;
CC       Q9NR20; P07900: HSP90AA1; NbExp=2; IntAct=EBI-3914009, EBI-296047;
CC       Q9NR20; P08238: HSP90AB1; NbExp=2; IntAct=EBI-3914009, EBI-352572;
CC       Q9NR20; O15344: MID1; NbExp=3; IntAct=EBI-3914009, EBI-2340316;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasm
CC       {ECO:0000269|PubMed:17292540}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Cytoplasm
CC       {ECO:0000269|PubMed:21127067}. Nucleus {ECO:0000269|PubMed:21127067}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q9NR20-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NR20-2; Sequence=VSP_013745;
CC       Name=3;
CC         IsoId=Q9NR20-3; Sequence=VSP_057132;
CC       Name=4; Synonyms=DYRK4-L;
CC         IsoId=Q9NR20-4; Sequence=VSP_057133;
CC       Name=5;
CC         IsoId=Q9NR20-5; Sequence=VSP_057134;
CC   -!- PTM: Autophosphorylation on Tyr-264 in the activation loop is required
CC       for kinase activity. {ECO:0000269|PubMed:21127067}.
CC   -!- MISCELLANEOUS: [Isoform 1]: May be due to a competing acceptor splice
CC       site.
CC   -!- MISCELLANEOUS: [Isoform 5]: Due to an alternative splicing donor site
CC       in exon 19. Markedly reduced enzymatic activity.
CC       {ECO:0000269|PubMed:21127067}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. MNB/DYRK subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF91393.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AK308260; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF263541; AAF91393.1; ALT_INIT; mRNA.
DR   EMBL; AK292322; BAF85011.1; -; mRNA.
DR   EMBL; AK308260; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC031244; AAH31244.1; -; mRNA.
DR   EMBL; Y09305; CAA70488.1; -; mRNA.
DR   CCDS; CCDS8530.1; -. [Q9NR20-1]
DR   RefSeq; NP_003836.1; NM_003845.2. [Q9NR20-1]
DR   AlphaFoldDB; Q9NR20; -.
DR   SMR; Q9NR20; -.
DR   BioGRID; 114326; 22.
DR   IntAct; Q9NR20; 30.
DR   STRING; 9606.ENSP00000441755; -.
DR   BindingDB; Q9NR20; -.
DR   ChEMBL; CHEMBL1075115; -.
DR   GuidetoPHARMACOLOGY; 2013; -.
DR   iPTMnet; Q9NR20; -.
DR   PhosphoSitePlus; Q9NR20; -.
DR   BioMuta; DYRK4; -.
DR   DMDM; 68566308; -.
DR   EPD; Q9NR20; -.
DR   jPOST; Q9NR20; -.
DR   MassIVE; Q9NR20; -.
DR   MaxQB; Q9NR20; -.
DR   PaxDb; Q9NR20; -.
DR   PeptideAtlas; Q9NR20; -.
DR   PRIDE; Q9NR20; -.
DR   ProteomicsDB; 82254; -. [Q9NR20-1]
DR   ProteomicsDB; 82255; -. [Q9NR20-2]
DR   Antibodypedia; 22291; 294 antibodies from 27 providers.
DR   DNASU; 8798; -.
DR   Ensembl; ENST00000010132.6; ENSP00000010132.5; ENSG00000010219.14. [Q9NR20-1]
DR   Ensembl; ENST00000540757.6; ENSP00000441755.1; ENSG00000010219.14. [Q9NR20-1]
DR   GeneID; 8798; -.
DR   KEGG; hsa:8798; -.
DR   UCSC; uc001qmx.5; human. [Q9NR20-1]
DR   CTD; 8798; -.
DR   DisGeNET; 8798; -.
DR   GeneCards; DYRK4; -.
DR   HGNC; HGNC:3095; DYRK4.
DR   HPA; ENSG00000010219; Tissue enhanced (testis).
DR   MIM; 609181; gene.
DR   neXtProt; NX_Q9NR20; -.
DR   OpenTargets; ENSG00000010219; -.
DR   PharmGKB; PA27552; -.
DR   VEuPathDB; HostDB:ENSG00000010219; -.
DR   eggNOG; KOG0667; Eukaryota.
DR   GeneTree; ENSGT00940000159401; -.
DR   HOGENOM; CLU_000288_5_9_1; -.
DR   InParanoid; Q9NR20; -.
DR   OrthoDB; 870358at2759; -.
DR   PhylomeDB; Q9NR20; -.
DR   TreeFam; TF314624; -.
DR   BRENDA; 2.7.12.1; 2681.
DR   PathwayCommons; Q9NR20; -.
DR   SignaLink; Q9NR20; -.
DR   SIGNOR; Q9NR20; -.
DR   BioGRID-ORCS; 8798; 11 hits in 1112 CRISPR screens.
DR   ChiTaRS; DYRK4; human.
DR   GenomeRNAi; 8798; -.
DR   Pharos; Q9NR20; Tchem.
DR   PRO; PR:Q9NR20; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q9NR20; protein.
DR   Bgee; ENSG00000010219; Expressed in left testis and 167 other tissues.
DR   ExpressionAtlas; Q9NR20; baseline and differential.
DR   Genevisible; Q9NR20; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; IBA:GO_Central.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IBA:GO_Central.
DR   Gene3D; 3.30.10.30; -; 1.
DR   InterPro; IPR042521; DYRK.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasm; Kinase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Tyrosine-protein kinase.
FT   CHAIN           1..520
FT                   /note="Dual specificity tyrosine-phosphorylation-regulated
FT                   kinase 4"
FT                   /id="PRO_0000085940"
FT   DOMAIN          104..400
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..32
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          404..467
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        406..421
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        422..461
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        230
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         110..118
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         133
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         183..186
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         264
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:21127067"
FT   VAR_SEQ         1
FT                   /note="M -> MQLLPPPIRTGTKTQMDAKKPRKCDLTPFLVLKARKKQKFTSAKVGS
FT                   KLSVQIQKPPSNIKNSRMTQVFHKNTSVTSLPFVDTKGKKNTVSFPHISKKVLLKSSLL
FT                   YQENQAHNQM (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_057132"
FT   VAR_SEQ         1
FT                   /note="M -> MQLLPPPIRTGTKTQMDAKKPRKCDLTPFLVLKARKKQKFTSAKGPT
FT                   LSEIYMVGSKLSVQIQKPPSNIKNSRMTQVFHKNTSVTSLPFVDTKGKKNTVSFPHISK
FT                   KVLLKSSLLYQENQAHNQM (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:21127067"
FT                   /id="VSP_057133"
FT   VAR_SEQ         380..382
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:21127067"
FT                   /id="VSP_057134"
FT   VAR_SEQ         441
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11062477,
FT                   ECO:0000303|PubMed:9748265"
FT                   /id="VSP_013745"
FT   VARIANT         61
FT                   /note="A -> T (in dbSNP:rs12306130)"
FT                   /id="VAR_033900"
FT   VARIANT         70
FT                   /note="A -> S"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040465"
FT   VARIANT         95
FT                   /note="V -> I (in dbSNP:rs746486416)"
FT                   /evidence="ECO:0000269|PubMed:11062477"
FT                   /id="VAR_010721"
FT   VARIANT         189
FT                   /note="N -> S (in dbSNP:rs3741927)"
FT                   /evidence="ECO:0000269|PubMed:11062477"
FT                   /id="VAR_010722"
FT   VARIANT         454
FT                   /note="D -> V (in dbSNP:rs1801016)"
FT                   /id="VAR_014948"
FT   MUTAGEN         133
FT                   /note="K->R: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:17292540"
FT   MUTAGEN         264
FT                   /note="Y->F: Abolishes kinase activity."
FT                   /evidence="ECO:0000269|PubMed:21127067"
FT   CONFLICT        165
FT                   /note="N -> I (in Ref. 2; BAF85011)"
FT                   /evidence="ECO:0000305"
FT   MOTIF           Q9NR20-4:19..37
FT                   /note="Bipartite nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:21127067"
SQ   SEQUENCE   520 AA;  59608 MW;  33FECD8249DDB223 CRC64;
     MPASELKASE IPFHPSIKTQ DPKAEEKSPK KQKVTLTAAE ALKLFKNQLS PYEQSEILGY
     AELWFLGLEA KKLDTAPEKF SKTSFDDEHG FYLKVLHDHI AYRYEVLETI GKGSFGQVAK
     CLDHKNNELV ALKIIRNKKR FHQQALMELK ILEALRKKDK DNTYNVVHMK DFFYFRNHFC
     ITFELLGINL YELMKNNNFQ GFSLSIVRRF TLSVLKCLQM LSVEKIIHCD LKPENIVLYQ
     KGQASVKVID FGSSCYEHQK VYTYIQSRFY RSPEVILGHP YDVAIDMWSL GCITAELYTG
     YPLFPGENEV EQLACIMEVL GLPPAGFIQT ASRRQTFFDS KGFPKNITNN RGKKRYPDSK
     DLTMVLKTYD TSFLDFLRRC LVWEPSLRMT PDQALKHAWI HQSRNLKPQP RPQTLRKSNS
     FFPSETRKDK VQGCHHSSRK ADEITKETTE KTKDSPTKHV QHSGDQQDCL QHGADTVQLP
     QLVDAPKKSE AAVGAEVSMT SPGQSKNFSL KNTNVLPPIV
//
